"Leukemia P388" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Descriptor ID |
D007941
|
| MeSH Number(s) |
C04.557.337.372.782 C04.619.531.782
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Leukemia P388".
Below are MeSH descriptors whose meaning is more specific than "Leukemia P388".
This graph shows the total number of publications written about "Leukemia P388" by people in this website by year, and whether "Leukemia P388" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia P388" by people in Profiles.
-
Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes. J Med Chem. 1997 Jan 03; 40(1):112-6.
-
Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol. 1996 May; 49(5):832-41.
-
Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice. Anticancer Drugs. 1995 Dec; 6(6):763-70.
-
Biochemical pharmacology of penclomedine (NSC-338720). Biochem Pharmacol. 1995 Oct 12; 50(8):1157-64.
-
Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties. Cancer Res. 1994 Mar 15; 54(6):1479-84.
-
In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes. Cancer Res. 1993 Apr 01; 53(7):1583-9.
-
Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity. Anticancer Drugs. 1993 Feb; 4(1):37-48.
-
3'-Hydroxyesorubicin halogenated at C-2'. J Antibiot (Tokyo). 1992 Mar; 45(3):386-93.
-
Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice. Oncology. 1992; 49(3):223-6.
-
Antitumor agents, 119. Kansuiphorins A and B, two novel antileukemic diterpene esters from Euphorbia kansui. J Nat Prod. 1991 May-Jun; 54(3):823-9.